404 related articles for article (PubMed ID: 11350861)
1. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
Yoshikawa T; Yoshida N; Oka M
Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861
[TBL] [Abstract][Full Text] [Related]
2. Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT(3) receptor antagonist, in ferrets.
Yoshikawa T; Yoshida N; Oka M
Eur J Pharmacol; 2001 Nov; 431(3):361-4. PubMed ID: 11730730
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
[TBL] [Abstract][Full Text] [Related]
5. Involvement of dopamine D3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret.
Yoshikawa T; Yoshida N; Hosoki K
Eur J Pharmacol; 1996 Apr; 301(1-3):143-9. PubMed ID: 8773458
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of AS-9705, a novel benzotriazolecarboxamide derivative, as a gastroprokinetic agent with potent anti-emetic activity.
Yoshikawa T; Mine Y; Morikage K; Yoshida N
Arzneimittelforschung; 2003; 53(2):98-106. PubMed ID: 12642965
[TBL] [Abstract][Full Text] [Related]
7. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
Yoshida N; Omoya H; Ito T
J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
[TBL] [Abstract][Full Text] [Related]
8. A dopamine D3 receptor agonist, 7-OH-DPAT, causes vomiting in the dog.
Yoshida N; Yoshikawa T; Hosoki K
Life Sci; 1995; 57(21):PL347-50. PubMed ID: 7475938
[TBL] [Abstract][Full Text] [Related]
9. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
[TBL] [Abstract][Full Text] [Related]
10. BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.
Gylys JA; Wright RN; Nicolosi WD; Buyniski JP; Crenshaw RR
J Pharmacol Exp Ther; 1988 Mar; 244(3):830-7. PubMed ID: 2978041
[TBL] [Abstract][Full Text] [Related]
11. RS 42358-197, a novel and potent 5-HT3 receptor antagonist, in vitro and in vivo.
Eglen RM; Lee CH; Smith WL; Johnson LG; Whiting RL; Hegde SS
J Pharmacol Exp Ther; 1993 Aug; 266(2):535-43. PubMed ID: 8355189
[TBL] [Abstract][Full Text] [Related]
12. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
13. Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia.
Millan MJ; Audinot V; Melon C; Newman-Tancredi A
Eur J Pharmacol; 1995 Jul; 280(2):225-9. PubMed ID: 7589191
[TBL] [Abstract][Full Text] [Related]
14. 5-HT3 receptor antagonist effects of DAT-582, (R) enantiomer of AS-5370.
Yoshida N; Omoya H; Kato S; Ito T
Eur J Pharmacol; 1992 Jun; 216(3):435-40. PubMed ID: 1425931
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo.
Eglen RM; Lee CH; Smith WL; Johnson LG; Clark R; Whiting RL; Hegde SS
Br J Pharmacol; 1995 Feb; 114(4):860-6. PubMed ID: 7773547
[TBL] [Abstract][Full Text] [Related]
16. The anti-emetic activity of GK-128 in Suncus murinus.
Ito C; Isobe Y; Kijima H; Kiuchi Y; Ohtsuki H; Kawamura R; Tsuchida K; Higuchi S
Eur J Pharmacol; 1995 Oct; 285(1):37-43. PubMed ID: 8846809
[TBL] [Abstract][Full Text] [Related]
17. Apomorphine-induced emesis in dogs: differential sensitivity to established and novel dopamine D2/5-HT(1A) antipsychotic compounds.
Depoortère R; Barret-Grévoz C; Bardin L; Newman-Tancredi A
Eur J Pharmacol; 2008 Nov; 597(1-3):34-8. PubMed ID: 18773888
[TBL] [Abstract][Full Text] [Related]
18. Development of high-affinity 5-HT3 receptor antagonists. 2. Two novel tricyclic benzamides.
Youssefyeh RD; Campbell HF; Airey JE; Klein S; Schnapper M; Powers M; Woodward R; Rodriguez W; Golec S; Studt W
J Med Chem; 1992 Mar; 35(5):903-11. PubMed ID: 1548679
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of 5-HT4 receptors, in addition to 5-HT3 receptors, in the emesis induced by high-dose cisplatin in Suncus murinus.
Horikoshi K; Yokoyama T; Kishibayashi N; Ohmori K; Ishii A; Karasawa A
Jpn J Pharmacol; 2001 Jan; 85(1):70-4. PubMed ID: 11243577
[TBL] [Abstract][Full Text] [Related]
20. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
